We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 129

Patent decisions on patents for chiral compounds
  • Bird & Bird
  • United Kingdom
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre


UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly
  • Bird & Bird
  • United Kingdom
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine


High Court’s rejection of du Pont’s UK paediatric SPC extension for Cozaar overturned by the Court of Appeal
  • Bird & Bird
  • United Kingdom
  • October 13 2009

In E I du Pont Nemours & Co.’s SPC Application (2009 EWHC 1112 (Ch)) the High Court considered an appeal from a decision of the UK Intellectual Property Office to refuse a six month extension of a Supplementary Protection Certificate covering Cozaar (Losartan, an antihypertensive) under the Paediatric Regulation 19012006


Paedriatric SPC extension: zero or negative term SPCs
  • Bird & Bird
  • European Union, United Kingdom
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States


The Court of Appeal’s recent decision on the parallel import of pharmaceutical products
  • Bird & Bird
  • United Kingdom
  • February 28 2008

Following two preliminary references to the European Court of Justice (“ECJ”), on 21 February 2008, the Court of Appeal handed down the latest decision in the long running pharmaceutical parallel import case of Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited (2008 EWCA Civ 83


Edwards Lifesciences AG v Cook Biotech Incorporated
  • Bird & Bird
  • United Kingdom
  • July 17 2009

Mr Justice Kitchin handed down a decision only four weeks after the hearing, finding Cook’s patent invalid and not infringed by Edwards’ SAPIEN heart valve


Does requesting and receiving approval for a pharmaceutical create a threat of patent infringement? A German perspective
  • Bird & Bird
  • Germany
  • February 28 2008

Under German law, neither the application for a marketing approval nor obtaining it constitutes a ‘use’ act under Section 9 German Patent Act


End of German Olanzapine battle: Federal Supreme Court upholds patent
  • Bird & Bird
  • Germany
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance


Confidentiality in clinical trials
  • Bird & Bird
  • Netherlands
  • October 16 2008

Confidentiality covering clinical trials is important in the context of obtaining patent protection for an invention that is the subject of a clinical trial


New regulations for medical devices
  • Bird & Bird
  • Spain
  • December 15 2009

On 6 November 2009, two new regulations reshaping the framework for medical devices were published in the Spanish Official Gazette